Accuray begins sale of VitalHold solution for Radixact system in Japan

Accuray has initiated sales of the VitalHold package supporting surface-guided radiation therapy – SGRT – on the Radixact System in Japan beginning November 30. The VitalHold feature incorporates SGRT capability on the Radixact System using the Catalyst+ HD system manufactured by C-RAD, making it possible to deliver deep inspiration breath hold – DIBH – treatments, primarily for breast cancers, and perform markerless patient setup. The addition of this new feature will enable medical teams using the Radixact System to offer a wider range of radiotherapy treatment options using one device. Heart dose from left-sided breast radiotherapy has been associated with a risk of cardiac injury. In recent years, DIBH irradiation has become the standard of care for the treatment of left breast cancer to help minimize the heart dose.